Cleveland Clinic, RIKEN, IBM named Gordon Bell finalists

Details

The Gordon Bell Prize, awarded annually at SC (Supercomputing) conference, recognizes outstanding achievement in high-performance computing applied to science. This year's finalists include a collaboration between Cleveland Clinic, Japan's RIKEN institute, and IBM Research, recognized for advances in automated quantum-HPC chemistry workflows. The source content for this announcement is minimal, providing only a high-level summary. The work appears to bridge quantum computing and classical HPC to automate complex chemistry simulations — a research direction IBM has been pursuing through its quantum computing roadmap and partnerships with research hospitals and national labs. Gordon Bell finalist status is a credible signal that the work has passed peer review from the HPC community, though finalist recognition does not guarantee the prize. The full technical details are expected to emerge at the SC26 conference proceedings. Given the thin content available, readers interested in the methodology should consult the IBM Research blog directly or the SC26 proceedings when published.